A $300 Billion Reason to Keep Drugs Cheap in India
Capsules spill out from the edge of a bottle on a pharmacy counter (Photographer: Simon Dawson/Bloomberg)

A $300 Billion Reason to Keep Drugs Cheap in India

(Bloomberg Gadfly) -- Global pharmaceutical companies have bemoaned for years India's capricious policies on prices and patents. Now the government needs billions of dollars for its "Make in India"...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.